Product Information

Home Product

About Masport®

Botulinum Toxin Type A

Masport® is a lyophilized botulinum toxin type A preparation indicated for both cosmetic and therapeutic applications. With over 12 years of market presence and more than 6 million injections administered annually, Masport® has established itself as a trusted choice for healthcare professionals worldwide.

Our Products

Masport® Product Range

Available in three unit strengths to meet various clinical needs and treatment requirements

Masport 500 Units

Masport® 500 Units

Our flagship product - ideal for larger treatment areas and multiple injection sites.

Most popular choice for comprehensive treatments

Most Popular
Masport 300 Units

Masport® 300 Units

Versatile mid-range option suitable for moderate treatment areas and standard therapeutic applications.

Masport 150 Units

Masport® 150 Units

Perfect for smaller treatment areas and targeted cosmetic applications requiring precise dosing.

Specifications

Product Details

Dosage Form

Lyophilized

Freeze-dried powder for reconstitution with sterile Sodium Chloride 0.9% solution.

Presentations

150, 300, 500 Units

Available in three unit strengths to meet various clinical needs and treatment requirements.

Storage Condition

2-8°C

Store in refrigerator between 2°C and 8°C. Do not freeze. Protect from light.

Reconstitution

Preparation Instructions

Masport® must be reconstituted using sterile Sodium Chloride 0.9% solution before administration.

MASPORT® Required Solvent per Vial Final Concentration (U/0.1 ml)
MASPORT® 500 2.5 ml 20
MASPORT® 300 1.5 ml 20
MASPORT® 150 1 ml 15
Important Notice: Do not inject intravenously (IV). Masport® is for intramuscular injection only and must be administered by qualified healthcare professionals.

Key Features

Why Choose Masport®?

Proven Track Record

Over 12 years of successful market presence with demonstrated safety and efficacy.

Long-Lasting Efficacy

Clinical studies demonstrate efficacy duration up to 180 days for glabellar lines.

Clinical Validation

Phase III clinical studies comparing Masport® with Dysport® show comparable safety and efficacy.

Multiple Applications

Indicated for both cosmetic (facial wrinkles) and therapeutic (spasticity, hyperhidrosis, etc.) applications.

Interested in Masport®?

Contact us to request a quote or learn more about how Masport® can benefit your practice.

Request a Quote